Weight Management
BATCH 04-26 · LIVELAB-VERIFIED01 / 01
Retatrutide·Research-grade peptide
Retatrutide
Triple-agonist metabolic peptide
Triple-agonist research peptide targeting GLP-1, GIP, and glucagon receptors for metabolic research.
Purity
99%
Weight
10 mg
Half-life
—
Route
—
10mg vial · 10 mg
$90
Retatrutide
✓ In stock
1
↻ Subscribe coming soonFree shipping from $250
RX. SUGGESTED PROTOCOL
Retatrutide engages three receptor pathways simultaneously: GLP-1, GIP, and glucagon. Relevant research applications cover weight loss mechanisms, insulin sensitivity, glucose regulation, cardiovascular marker changes, liver health, and energy expenditure modeling.
CYCLE
—
ROUTE
—
For research use only.
Intended strictly for in-vitro research and laboratory use. Not for human consumption. Not evaluated by the FDA. No statements on this page are intended to diagnose, treat, cure, or prevent any disease.
FROM THE CATALOGPairs well with
